McNeil Reaches Consumer Cholesterol Testing Licensing Deal With IMI
This article was originally published in The Tan Sheet
Executive Summary
McNeil Consumer Health is seeking to leverage the potential Rx-to-OTC switch of J&J/Merck's Mevacor (lovastatin) with an agreement to license International Medical Innovations' predictive tests for coronary artery disease (CAD)